About this trial
Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.
Eligibility criteria
Qualifiers
Chronic alcohol intake, Identified with AUDIT(Alcohol Use Disorder Inventory Test) Questionnaire
Active alcohol use until 4 weeks prior to presentation
ALT and AST elevated >1.5 times the upper limit of normal
Over 1.5 ratio of AST to ALT
Disqualifiers
Severe alcoholic hepatitis with cirrhosis or life expectancy less than 3 months
Severe renal impairment (Glomerular filtration rate below 60 ml/min per 1.73m2)
Hepatic disorders due to cardiac causes, inherited metabolic causes, hemochromatosis and Wilson's disease
Participants with active viral hepatitis
Trial design
Treatments tested in this trial
- Livitol-70